000 | 01160 a2200325 4500 | ||
---|---|---|---|
005 | 20250517221630.0 | ||
264 | 0 | _c20190517 | |
008 | 201905s 0 0 eng d | ||
022 | _a1879-016X | ||
024 | 7 |
_a10.1016/j.pharmthera.2018.05.014 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWei, Min | |
245 | 0 | 0 |
_aTargeting phosphatases of regenerating liver (PRLs) in cancer. _h[electronic resource] |
260 |
_bPharmacology & therapeutics _c10 2018 |
||
300 |
_a128-138 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 |
_aDrug Development _xmethods |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aProtein Tyrosine Phosphatases _xantagonists & inhibitors |
700 | 1 | _aKorotkov, Konstantin V | |
700 | 1 | _aBlackburn, Jessica S | |
773 | 0 |
_tPharmacology & therapeutics _gvol. 190 _gp. 128-138 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pharmthera.2018.05.014 _zAvailable from publisher's website |
999 |
_c28487772 _d28487772 |